Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Immunogen Inc | 17,503,417 | 16,423,922 | -1,079,495 | $277.78M | $486.97M | 17.42% | +$209.19M |
| Krystal Biotech, Inc.(KRYS) | 2,003,367 | 1,733,189 | -270,178 | $232.39M | $215.02M | 7.69% | -$17.37M |
| Amicus Therapeutics Inc COM | 16,944,621 | 14,828,321 | -2,116,300 | $206.05M | $210.41M | 7.53% | +$4.37M |
| Scholar Rock Holding Corporation(SRRK) | 4,733,248 | 6,402,505 | +1,669,257 | $33.61M | $120.37M | 4.31% | +$86.76M |
| Rayzebio Inc | 1,857,706 | 1,857,706 | 0 | $41.24M | $115.49M | 4.13% | +$74.25M |
| Augmedix Inc | 15,630,327 | 16,380,327 | +750,000 | $80.50M | $95.82M | 3.43% | +$15.33M |
| Deciphera Pharmaceuticals In | 4,475,384 | 4,801,540 | +326,156 | $56.93M | $77.45M | 2.77% | +$20.52M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 0 | 142,500 | +142,500 | $0 | $67.73M | 2.42% | +$67.73M |
| REGENXBIO Inc.(RGNX) | 2,574,042 | 3,760,690 | +1,186,648 | $42.37M | $67.50M | 2.41% | +$25.14M |
| Biohaven Ltd.(BHVN) | 518,924 | 1,444,365 | +925,441 | $13.50M | $61.82M | 2.21% | +$48.32M |
| Zymeworks Inc.(ZYME) | 5,661,230 | 5,790,230 | +129,000 | $35.89M | $60.16M | 2.15% | +$24.27M |
| LivaNova PLCSHS(LIVN) | 1,100,492 | 1,137,068 | +36,576 | $58.19M | $58.83M | 2.10% | +$637.9K |
| ALX Oncology Holdings Inc.(ALXO) | 1,283,289 | 3,659,264 | +2,375,975 | $6.16M | $54.49M | 1.95% | +$48.33M |
| Catalent Inc | 873,966 | 1,100,466 | +226,500 | $39.79M | $49.44M | 1.77% | +$9.65M |
| Fate Therapeutics, Inc.(FATE) | 13,124,427 | 13,169,057 | +44,630 | $27.82M | $49.25M | 1.76% | +$21.43M |
| Pliant Therapeutics, Inc.(PLRX) | 2,678,099 | 2,696,648 | +18,549 | $46.44M | $48.84M | 1.75% | +$2.40M |
| Kymera Therapeutics, Inc.(KYMR) | 1,868,507 | 1,823,956 | -44,551 | $25.97M | $46.44M | 1.66% | +$20.47M |
| Immunome, Inc.(IMNM) | 0 | 3,879,415 | +3,879,415 | $0 | $41.51M | 1.48% | +$41.51M |
| Immunovant, Inc.(IMVT) | 1,102,514 | 977,072 | -125,442 | $42.33M | $41.16M | 1.47% | -$1.16M |
| Boston Scientific Corporation(BSX) | 774,200 | 693,200 | -81,000 | $40.88M | $40.07M | 1.43% | -$803.9K |
| Shattuck Labs, Inc.(STTK) | 5,619,914 | 5,619,914 | 0 | $8.54M | $40.07M | 1.43% | +$31.53M |
| Celldex Therapeutics, Inc.(CLDX) | 1,635,938 | 993,803 | -642,135 | $45.02M | $39.41M | 1.41% | -$5.61M |
| Beam Therapeutics Inc.(BEAM) | 1,469,725 | 1,429,783 | -39,942 | $35.35M | $38.92M | 1.39% | +$3.57M |
| Absci Corporation | 8,031,094 | 8,031,094 | 0 | $10.60M | $33.73M | 1.21% | +$23.13M |
| Nurix Therapeutics, Inc.(NRIX) | 2,848,827 | 3,256,519 | +407,692 | $22.39M | $33.61M | 1.20% | +$11.22M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 935,863 | +935,863 | $0 | $33.30M | 1.19% | +$33.30M |
| Replimune Group, Inc.(REPL) | 4,163,922 | 3,865,258 | -298,664 | $71.24M | $32.58M | 1.17% | -$38.66M |
| Cabaletta Bio, Inc.(CABA) | 1,774,252 | 1,374,189 | -400,063 | $27.00M | $31.19M | 1.12% | +$4.19M |
| Abbott Labs | 0 | 265,500 | +265,500 | $0 | $29.22M | 1.05% | +$29.22M |
| Evolent Health, Inc.CL A(EVH) | 465,282 | 835,537 | +370,255 | $12.67M | $27.60M | 0.99% | +$14.93M |
| Akero Therapeutics Inc | 1,769,684 | 1,109,476 | -660,208 | $89.51M | $25.91M | 0.93% | -$63.60M |
| ADC Therapeutics SASHS(ADCT) | 14,178,045 | 15,328,317 | +1,150,272 | $12.72M | $25.45M | 0.91% | +$12.73M |
| Annexon, Inc.(ANNX) | 3,503,190 | 5,503,190 | +2,000,000 | $8.27M | $24.98M | 0.89% | +$16.72M |
| Igm Biosciences Inc | 2,971,542 | 2,971,542 | 0 | $24.81M | $24.69M | 0.88% | -$118.9K |
| Verve Therapeutics Inc | 809,777 | 1,718,669 | +908,892 | $10.74M | $23.96M | 0.86% | +$13.22M |
| Penumbra, Inc.(PEN) | 155,076 | 95,242 | -59,834 | $37.51M | $23.96M | 0.86% | -$13.56M |
| 89bio Inc | 761,955 | 1,969,402 | +1,207,447 | $11.76M | $22.00M | 0.79% | +$10.23M |
| Charles River Laboratories International, Inc.(CRL) | 66,382 | 86,782 | +20,400 | $13.01M | $20.52M | 0.73% | +$7.51M |
| Entrada Therapeutics, Inc.(TRDA) | 1,284,000 | 1,283,735 | -265 | $20.29M | $19.37M | 0.69% | -$915.6K |
| Neurogene Inc.(NGNE) | 0 | 946,897 | +946,897 | $0 | $18.35M | 0.66% | +$18.35M |
| Intuitive Surgical, Inc.(ISRG) | 0 | 54,258 | +54,258 | $0 | $18.30M | 0.65% | +$18.30M |
| HCA Healthcare, Inc.(HCA) | 24,667 | 66,100 | +41,433 | $6.07M | $17.89M | 0.64% | +$11.82M |
| Cogent Biosciences, Inc.(COGT) | 2,053,333 | 2,914,022 | +860,689 | $20.02M | $17.13M | 0.61% | -$2.89M |
| Stryker Corporation(SYK) | 94,738 | 53,141 | -41,597 | $25.89M | $15.91M | 0.57% | -$9.98M |
| Repare Therapeutics Inc | 2,404,695 | 2,148,748 | -255,947 | $29.05M | $15.69M | 0.56% | -$13.36M |
| Stoke Therapeutics, Inc.(STOK) | 3,872,696 | 2,625,506 | -1,247,190 | $15.26M | $13.81M | 0.49% | -$1.45M |
| Align Technology Inc | 0 | 50,082 | +50,082 | $0 | $13.72M | 0.49% | +$13.72M |
| Gritstone Bio Inc | 8,509,126 | 5,872,605 | -2,636,521 | $14.64M | $11.98M | 0.43% | -$2.66M |
| Prime Medicine, Inc.(PRME) | 1,324,350 | 1,324,350 | 0 | $12.63M | $11.73M | 0.42% | -$900.6K |
| Elevance Health, Inc.(ELV) | 85,378 | 23,079 | -62,299 | $37.18M | $10.88M | 0.39% | -$26.29M |
| Allakos Inc | 4,135,061 | 3,670,447 | -464,614 | $9.39M | $10.02M | 0.36% | +$633.7K |
| AC Immune SASHS(ACIU) | 0 | 2,000,000 | +2,000,000 | $0 | $10.00M | 0.36% | +$10.00M |
| Rapt Therapeutics Inc | 427,490 | 366,776 | -60,714 | $7.10M | $9.11M | 0.33% | +$2.01M |
| Stereotaxis, Inc.(STXS) | 5,765,792 | 3,402,443 | -2,363,349 | $9.11M | $5.95M | 0.21% | -$3.16M |
| Invivyd, Inc.(IVVD) | 1,440,725 | 1,440,725 | 0 | $2.45M | $5.68M | 0.20% | +$3.23M |
| Science 37 Holdings Inc | 0 | 990,412 | +990,412 | $0 | $5.29M | 0.19% | +$5.29M |
| Atara Biotherapeutics Inc | 6,280,813 | 9,106,446 | +2,825,633 | $9.30M | $4.67M | 0.17% | -$4.63M |
| Nuvation Bio Inc.CL A(NUVB) | 3,031,009 | 3,031,009 | 0 | $4.06M | $4.58M | 0.16% | +$515.3K |
| Lava Therapeutics NvSHS | 2,074,372 | 2,074,372 | 0 | $3.09M | $3.28M | 0.12% | +$186.7K |
| Medavail Holdings Inc | 692,082 | 692,082 | 0 | $4.19M | $3.05M | 0.11% | -$1.14M |
| Xeris Biopharma Holdings Inc | 1,046,587 | 1,046,587 | 0 | $1.95M | $2.46M | 0.09% | +$512.8K |
| Achilles Therapeutics PlcADS | 1,608,089 | 1,608,089 | 0 | $1.46M | $1.43M | 0.05% | -$33.6K |
| Allovir Inc | 1,907,969 | 1,907,969 | 0 | $4.10M | $1.30M | 0.05% | -$2.81M |
| Somalogic IncCL A | 399,439 | 370,839 | -28,600 | $954.7K | $938.2K | 0.03% | -$16.4K |
| Invitae Corp | 2,280,403 | 1,474,026 | -806,377 | $1.38M | $923.9K | 0.03% | -$456.2K |
| Hookipa Pharma Inc | 1,063,769 | 1,063,769 | 0 | $655.3K | $861.7K | 0.03% | +$206.4K |
| Alpha Teknova, Inc.(TKNO) | 284,564 | 161,005 | -123,559 | $793.9K | $600.5K | 0.02% | -$193.4K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 715,607 | 715,607 | 0 | $558.2K | $567.5K | 0.02% | +$9.3K |
| Ventyx Biosciences Inc | 929,900 | 207,203 | -722,697 | $32.30M | $511.8K | 0.02% | -$31.78M |
| Atreca IncCL A | 442,653 | 442,653 | 0 | $115.5K | $58.4K | 0.00% | -$57.1K |
| CUTERA INCCOM | 334,996 | 0 | -334,996 | $2.02M | $0 | — | -$2.02M |
| DEXCOM INCCOM(DXCM) | 244,391 | 0 | -244,391 | $22.80M | $0 | — | -$22.80M |
| HUMANA INCCOM(HUM) | 59,851 | 0 | -59,851 | $29.12M | $0 | — | -$29.12M |
| NEOLEUKIN THERAPEUTICS INCCOM NEW | 582,443 | 0 | -582,443 | $2.30M | $0 | — | -$2.30M |
| SCIENCE 37 HOLDINGS INCCOM | 19,808,234 | 0 | -19,808,234 | $7.92M | $0 | — | -$7.92M |
| SONENDO INCCOM | 410,393 | 0 | -410,393 | $306.1K | $0 | — | -$306.1K |
| XENON PHARMACEUTICALS INCCOM(XENE) | 419,568 | 0 | -419,568 | $14.33M | $0 | — | -$14.33M |